Abstract:Constitutively active KRAS mutations have been found to be involved in various processes of cancer development, and render tumor cells resistant to EGFR-targeted therapies. Mutation detection methods with higher sensitivity will increase the possibility of choosing the correct individual therapy. Here, we established a highly sensitive and efficient microfluidic capillary electrophoresis-based restriction fragment length polymorphism (µCE-based RFLP) platform for low-abundance KRAS genotyping with the combination of µCE and RFLP techniques. By using our self-built sensitive laser induced fluorescence (LIF) detector and a new DNA intercalating dye YOYO-1, the separation conditions of µCE for ΦX174 HaeIII DNA marker were first optimized. Then, a Mav I digested 107-bp KRAS gene fragment was directly introduced into the microfluidic device and analyzed by µCE, in which field amplified sample stacking (FASS) technique was employed to obtain the enrichment of the RFLP digestion products and extremely improved the sensitivity. The accurate analysis of KRAS statuses in HT29, LS174T, CCL187, SW480, Clone A, and CX-1 colorectal cancer (CRC) cell lines by µCE-based RFLP were achieved in 5 min with picoliter-scale sample consumption, and as low as 0.01% of mutant KRAS could be identified from a large excess of wild-type genomic DNA (gDNA). In 98 paraffin-embedded CRC tissues, KRAS codon 12 mutations were discovered in 28 (28.6%), significantly higher than that obtained by direct sequencing (13, 13.3%). Clone sequencing confirmed these results and showed this system could detect at least 0.4% of the mutant KRAS in CRC tissue slides. Compared with direct sequencing, the new finding of the µCE-based RFLP platform was that KRAS mutations in codon 12 were correlated with the patient's age. In conclusion, we established a sensitive, fast, and cost-effective screening method for KRAS mutations, and successfully detected low-abundance KRAS mutations in clinical samples, which will allow provision of more precise individualized cancer therapy.

Rapid detection of K-ras oncogene point mutation by real-time fluorescence allele-specific amplification

K-ras Point Mutation Detection in Colorectal Cancer:Comparison of Two Approaches Using Allele Specific Amplification

Detection of K-ras point mutation by unmodified gold nanoparticles and allele-specific amplification

A Novel Mutant Allele Specific Amplification and Electrochemiluminescence Method for the Detection of Point Mutation in Clinical Samples.

Lateral flow strip for visual detection of K-ras mutations based on allele-specific PCR

Highly Sensitive ECL-PCR Method for Detection of K-ras Point Mutation

A Novel Assay Coupling Dephosphorylation and Blue/White Colony Screening for the G > A Hotspot Mutation at Codon 13 of KRAS Gene

A Label-Free Colorimetric Isothermal Cascade Amplification for the Detection of Disease-Related Nucleic Acids Based on Double-Hairpin Molecular Beacon.

Palindromic Molecular Beacon-Based Intramolecular Strand-Displacement Amplification Strategy for Ultrasensitive Detection of K-ras Gene.

Rapid and Sensitive Detection of KRAS Mutation after Fast-Cold-pcr Enrichment and High-Resolution Melting Analysis.

Sensitive Detection of Point Mutation Using Exponential Strand Displacement Amplification-Based Surface Enhanced Raman Spectroscopy

Detection of K-ras Point Mutation in Pancreatic Cancer Electrochemiluminescence-Polymerase Chain Reaction

Label-free Colorimetric Detection of Cancer Related Gene Based on Two-Step Amplification of Molecular Machine

An Enzymatic On/off Switch‐mediated Assay for KRAS Hotspot Point Mutation Detection of Circulating Tumor DNA

A Sensitive Assay Enriched with Blue/White Screening to Empower Sequencing Analysis for G > A Hotspot Mutation in Codon 13 of KRAS Gene

Establishment of pyrosequencing method for detection of k-ras mutation

Loopback Rolling Circle Amplification for Ultrasensitive Detection of Kras Gene

Detection of Low-Abundance KRAS Mutations in Colorectal Cancer Using Microfluidic Capillary Electrophoresis-Based Restriction Fragment Length Polymorphism Method with Optimized Assay Conditions.

KRAS Mutation Detection Method Based on LNA and Allele Specific Amplification

Detection of K-ras mutation in advanced colorectal carcinoma by Pyrosequencing

Rapid Detection of K-ras Gene Point Mutation in Pancreatic Adenocarcinoma by Pyrosequencing